CTCA implements technology to aid cancer treatment process


CTCA implements technology to aid cancer treatment process

Snowleopard1 / iStock

Cancer Treatment Centers of America (CTCA), in collaboration with NantHealth and Allscripts, is implementing a NantHealth clinical decision support solution called the Eviti that helps inform the cancer treatment process, without interrupting the physician's clinical workflow.

The direct interface of the clinical operating system (NantOS) was built with the input of hundreds of oncologists across the nation and holds a comprehensive collection of evolving cancer care data.

"Clinical Pathways presents all appropriate treatment options. It also helps eliminate potential guesswork by clinicians routinely inundated with new data and oncology research," said George Daneker, chief medical officer at CTCA at Southeastern Regional Medical Center.

"We created an ecosystem of treatment options, customized to the CTCA standard of care, for patients to review and choose from that's safe and efficient."

Designed with the patient in mind, Clinical Pathways integrates the latest cancer research available, treatment regimens and complementary therapies into the Allscripts Sunrise EHR, giving oncologists the ability to create a curated list of care protocols at the point of care.

Clinical Pathways creates greater transparency around therapeu­tic selection and care delivery, and also helps to improve quality and efficiency by reducing variability in care. With this integrated platform, patients and their clinical teams can discuss and compare treatment regimens, providing patients with greater confidence of the appropriateness of their prescribed treatment for their specific diagnosis.

Clinical Pathways can also expedite approval from insurance providers by effectively providing the necessary clinical data to support selected treatment strategies.

"Cancer Treatment Centers of America, Allscripts and NantHealth began planning this project in early 2016 to help patients and providers alike benefit from the clinical capabilities of an integrated solution," said Paul Black, Allscripts chief executive officer.

"Through a careful analysis of clinical workflows and strategic design sessions, we've delivered a solution that enhances and improves the chemotherapy regimen selection and ordering process, and ultimately, the quality of care CTCA provides to its patients."

Cancer Treatment Centers of America, NantHealth, Allscripts, US